Usefulness of prophylactic transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.

Authors:
  • KTKuniya Tanaka
    Kuniya Tanaka
  • HMHidenobu Masui
    Hidenobu Masui
  • KMKenichi Matsuo
    Kenichi Matsuo
  • DMDaisuke Morioka
    Daisuke Morioka
  • HKHaruki Kurosawa
    Haruki Kurosawa
  • YMYasuhiko Miura
    Yasuhiko Miura
  • IEItaru Endo
    Itaru Endo
  • HSHitoshi Sekido
    Hitoshi Sekido
  • HSHiroshi Shimada
    Hiroshi Shimada

  • 27 August 2005
    • journal article
Abstract
To improve the prognosis after hepatectomy for HCC, repeated postoperative transcatheter arterial infusions of anticancer drugs and lipiodol (TAI) were given. TAI may be effective as an adjuvant therapy for prevention of residual liver recurrence after hepatectomy, probably by suppression of the development of intrahepatic micrometastases rather than of multicentric carcinogenesis.